enVVeno Medical Corporation (NVNO)

4,9900 -0,2100 (-4,04%) A partir del 10:47AM EDT. Mercado abierto.

enVVeno Medical Corporation

70 Doppler
Irvine, CA 92618
United States
949 261 2900
https://www.envveno.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 31

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Robert A. Berman	CEO & Director	1,02M	N/A	1963
Mr. Craig Thomas Glynn	CFO, Treasurer & Secretary	313,69k	N/A	1961
Dr. Hamed Alavi Ph.D.	Senior VP & Chief Technology Officer	384,39k	N/A	N/A
Dr. Marc H. Glickman M.D.	Senior VP & Chief Medical Officer	491,59k	N/A	1949
Mr. Warren Hancock	Co-founder	N/A	N/A	N/A
Dr. Benedict Broennimann M.D.	Chief Medical Officer of Outside of United States	240k	N/A	1957
Mr. Andrew Cormack	Chief Commercial Officer	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Gobierno corporativo

El ISS Governance QualityScore de enVVeno Medical Corporation, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.